iGMDRD117
Canonical SMILES: CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
InChI: InChI=1S/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,52)/t26-,27-,28+,30-,31+,32+,33-,35-,41+,42-,43+/m0/s1
InChI Key: ZDZOTLJHXYCWBA-VCVYQWHSSA-N
Drug Class:
Antimitotic AgentsAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsCardiotoxic antineoplastic agentsCyclodecanesCycloparaffinsCytochrome P-450 Enzyme InhibitorsDiterpenesHydrocarbonsHydrocarbons, AlicyclicHydrocarbons, CyclicImmunosuppressive AgentsMacrocyclic CompoundsMicrotubule InhibitorsMitosis ModulatorsMyelosuppressive AgentsP-glycoprotein/ABCB1 SubstratesPolycyclic CompoundsTaxane DerivativesTaxoidsTerpenesTubulin ModulatorsDrug Targets:
MicrotubulesTUBB1 (Q9H4B7)BCL2 (P10415)MAP2 (P11137)MAP4 (P27816)MAPT (P10636)NR1I2 (O75469)Drug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Docetaxel
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |